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A convenient, economical and green approach to the synthesis of 1H-indazolo[1,2-b]phthalazine-1,6,11-trione derivatives has 
been achieved via a one-pot protocol using phthalhydrazide, a cyclic-β-diketone and an aldehyde in the presence of a ceric am-
monium nitrate catalyst in polyethylene glycol. The simple work up, mild conditions, excellent yields, inexpensive and non-toxic 
catalyst and simple solvent recyclability render this protocol both attractive and economically viable. 
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Multi-component reactions (MCRs) offer a number of fas-
cinating and challenging transformations in organic synthe-
sis [1–7]. Atom-economy, convergent character, operational 
simplicity, structural diversity, and complexity are the ma-
jor advantages associated with multi-component reactions. 
Furthermore, multi-component reactions are emerging as a 
powerful tool for the synthesis of biologically important 
compounds [8,9]. In drug discovery, as well as “Green 
Chemistry”, MCRs are the techniques of choice for the 
high-throughput synthesis of compounds from a cost- and 
time point of view [10,11].  
Over the past few decades, a tremendous upsurge of in-
terest has been observed in the synthesis of nitrogen-   
containing heterocyclic compounds, owing to their abun-
dance in nature and essentiality to life. Their applications to 
biologically active pharmaceuticals, agrochemicals, and 
functional materials are also becoming increasingly im-
portant [12–16]. Phthalazine derivatives, that comprise two 
bridgehead nitrogen atoms in a fused ring system, have at-
tracted considerable attention because of their pharmaco-
logical, and biological properties, and potential clinical ap-
plication [17–34]. These compounds have also proved to be 
promising luminescence materials and fluorescence probes 
[35]. Several methods have been reported for the synthesis 
of phthalazine derivatives [36–41]. Unfortunately, many of 
these methods are plagued with a number of limitations, 
such as harsh reaction conditions, unsatisfactory yields, 
tedious work-up procedures, relatively long reaction times, 
poor solvent scope and the use of stoichiometric and rela-
tively expensive reagents. Therefore, improved methods, in 
terms of operational simplicity, reusability and economic 
viability are highly desirable.  
Recently, ceric ammonium nitrate (CAN) has been uti-
lized for various organic transformations [42–45]. The most 
characteristic feature of CAN is that it can act as a water- 
compatible Lewis acid in aqueous solvents. Additionally, 
advantages such as low-cost, eco-friendly nature, ease of 
handling, non-toxic nature make CAN an attractive catalyst 
for a variety of synthetic transformations. Regulatory pres-
sures are increasingly focusing on the use, manufacture and 
disposal of organic solvents, and thus, the development of 
non-hazardous alternatives (one of the several goals for 
green chemistry and engineering) is vitally important for the 
continued and sustainable development of the chemical 
processes. Recently, polyethylene glycol (PEG) and solu-
tions thereof have been introduced as potential green   
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solvent systems [46–48]. They have replaced a number of 
other “neoteric solvents”, such as ionic liquids, super criti-
cal carbon dioxide, and micellar systems, whose toxicolog-
ical properties, short and long-term hazardous nature, and 
biodegradability are not completely understood. Their low 
cost, reduced flammability, reduced toxicity, recyclability, 
non-halogenated composition, easy degradability, and mis-
cibility with wide variety of organic solvents are just some 
of the key features that render PEG an attractive alternative 
solvent in organic synthesis [49–53]. Keeping within our 
theme of green chemistry and in a continuation of our stud-
ies for the development of cheap and environmentally be-
nign methodologies for organic synthesis [54–56], we de-
cided to examine the versatility of CAN as a catalyst    
and PEG 400 as solvent for the synthesis of 1H-          
indazolo[1,2-b]phthalazine-1,6,11-triones. 
1  Experimental  
1.1  Materials and methods 
All chemicals were used as received from Sigma-Aldrich 
without any further purification. All reactions were moni-
tored by thin-layer chromatography (TLC), using alumi- 
nium plates coated with silica gel F254; (Merck) using ethyl 
acetate, and hexane (40/60) as eluent. Spots were visualized 
using either UV light or an iodine chamber. Melting points 
were determined in using a Thomas Hoover melting point 
apparatus (uncorrected). IR spectra were recorded on a Per-
kin-Elmer FTIR-1710 spectrophotometer, using KBr pel-
lets/-nujol film. 1H and 13C NMR spectra were recorded on 
a JEOL JNM-ECX 400P FT NMR spectrometer with TMS 
as the internal standard. Chemical shifts are on a δ scale and 
coupling constant values (J) are in Hertz (Hz). Elemental 
analyses were performed on a Hereaus CHN rapid analyzer. 
The temperature of the reaction mixture was measured us-
ing a non-contact infrared mini gun thermometer (AZ 
minigun type, model 8868). 
1.2  General procedure for the synthesis of 1H-    
indazolo[1,2-b]phthalazine-1,6,11-trione derivatives 
To a 50 mL round-bottom flask, phthalhydrazide 1, alde-
hyde (RCHO) 2a2q, cyclic β-diketone 3a (C6H8O2), 3b 
(C8H12O2) and PEG 400 (2 mL) were added. CAN (5 mol%) 
was then added and reaction mixture was stirred at 50°C for 
the appropriate time, as summarized in Table 1. The pro-
gress of the reaction was monitored by TLC. Upon comple-
tion of the reaction, the mixture was cooled in a dry 
ice-acetone bath, to precipitate the PEG 400, and extracted 
with ether (PEG is insoluble in ether). The ether layer   
was decanted, dried over anhydrous Na2SO4 and concen-
trated under reduced pressure to afford the desired product. 
The crude product was purified by column chromatography 
on silica gel (100–200 mesh size), using hexane/ethyl ace-
tate as eluent. This provided the pure respective 1H-    
indazolo[1,2-b]phthalazine-1,6,11-trione derivative, (4a–4s). 
The recovered PEG 400 phase was reused for consecutive 
reactions. All products were characterized on the basis of 
their spectral analysis (IR, 1H NMR, 13C NMR and     
elemental analysis) and melting point determination 
[37,57–60].  
Table 1  CAN catalyzed synthesis of 1H-indazolo[1,2-b]phthalazine-1,6,11-trionesa) 
Entry R R' Product Time (h) Yield (%)b) 
 1 Ph (2a) H (3a) 4a 2 94 
 2 4-Br-C6H4 (2b) H 4b 2.5 92 
 3 3-NO2-C6H4 (2c) H 4c 3.5 94 
 4 4-Me-C6H4 (2d) H 4d 2 94 
 5 3-HO-C6H4 (2e) H 4e 2 92 
 6 4-HO-3-MeO-C6H3 (2f) H 4f 3 94 
 7 4-Me2N-C6H4 (2g) H 4g 2.5 90 
 8 Ph Me (3b) 4h 2 94 
 9 4-Cl-C6H4 (2h) Me 4i 2 90 
10 4-MeO-C6H4 (2i) Me 4j 2 92 
11 4-NO2-C6H4 (2j) Me 4k 3.5 90 
12 4-Me-C6H4 Me 4l 2.5 94 
13 2-HO-C6H4 (2k) Me 4m 2 90 
14 Piperonyl (2l) Me 4n 3 88 
15 2-HO-1-Naphthyl (2m) Me 4o 3.5 89 
16 Ethyl (2n) H  4p 4 62 
17 Propyl (2o) H  4q 4 64 
18 Isobutyl (2p) Me  4r 4 62 
19 Hexyl (2q) Me 4s 4 63 
a) Reaction conditions: phthalhydrazide 1 (1 mmol), aldehyde 2a–2q (1 mmol), cyclic β-diketone 3a, 3b (1 mmol); catalyst: CAN (5 mol%); T: 50°C; 
solvent: PEG 400 (2 mL). b) Isolated yields. 
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1.3  Spectral data for the synthesized compounds 
(1) 2,3,4,13-Tetrahydro-13-phenyl-1H-indazolo[1,2-b]phth- 
alazine-1,6,11-trione (4a). Yellow solid, mp. 222–225°C 
[58]. IR (KBr, νmax cm–1): 2920, 1655, 1630, 1360, 1310, 
1284, 754. 1H NMR (CDCl3, 400 MHz, TMS): δ 8.248.35 
(m, 2H), 7.807.88 (m, 2H), 7.177.38 (m, 5H, Ar-H), 6.42 
(s, 1H, Ar-CH), 3.263.63 (m, 2H), 2.412.64 (m, 2H), 
2.212.36 (m, 2H); 13C NMR (CDCl3, 100 MHz): δ 197.1, 
164.2, 157.3, 150.8, 145.5, 133.9, 129.4, 128.7, 127.8, 
127.3, 126.5, 119.4, 65.4, 36.3, 26.8, 21.4. Anal. Calcd. for 
C21H16N2O3 (%): C, 73.24; H, 4.68; N, 8.13; Found (%): C, 
73.11; H, 4.60; N, 8.05. 
(2) 2,3,4,13-Tetrahydro-13-(4-bromo-phenyl)-1H-indaz- 
olo[1,2-b]phthalazine-1,6,11-trione (4b).  Yellow solid, 
mp. 279–282°C [60]. IR (nujol, νmax cm–1): 2926, 1656, 
1621, 1368, 1309, 1284, 755, 668. 1H NMR (CDCl3, 400 
MHz, TMS): δ 8.23–8.37 (m, 2H), 7.82–7.88 (m, 2H), 
7.15–7.46 (m, 4H, Ar-H), 6.43 (s, 1H, Ar-CH), 3.43–3.66 
(m, 2H), 2.44–2.67 (m, 2H), 2.23–2.37 (m, 2H); 13C NMR 
(CDCl3, 100 MHz): δ 194.4, 155.6, 154.2, 153.2, 135.3, 
134.5, 132.8, 132.6, 129.4, 128.3, 127.9, 123.7, 120.3, 51.7, 
40.0, 36.5, 29.2. Anal. Calcd. for C21H15BrN2O3 (%): C, 
59.59; H, 3.57; N, 6.62; Found (%): C, 59.50; H, 3.52;    
N, 6.51. 
(3) 2,3,4,13-Tetrahydro-13-(3-nitro-phenyl)-1H-indazolo- 
[1,2-b]phthalazine-1,6,11-trione (4c).  Light yellow solid, 
mp. 228–232°C [59]. IR (KBr, νmax cm–1): 2923, 1667, 1624, 
1371, 1307, 1284, 958, 703. 1H NMR (CDCl3, 400 MHz, 
TMS): δ 8.24–8.34 (m, 2H), 7.81–7.87 (m, 2H), 7.29–7.45 
(m, 4H, Ar-H), 6.38 (s, 1H, Ar-CH), 3.46–3.64 (m, 2H), 
2.52–2.67 (m, 2H), 2.20–2.47 (m, 2H); 13C NMR (CDCl3, 
100 MHz): δ 196.2, 165.5, 156.0, 154.8, 153.4, 145.6, 135.2, 
134.8, 129.4, 128.6, 127.3, 124.5, 120.4, 116.4, 64.2, 36.8, 
26.9, 21.3. Anal. Calcd. for C21H15N3O5 (%): C, 64.78; H, 
3.88; N, 10.79; Found (%): C, 64.65; H, 3.76; N, 10.65.   
(4) 2,3,4,13-Tetrahydro-13-(4-methyl-phenyl)-1H-inda- 
zolo[1,2-b]phthalazine-1,6,11-trione (4d). Yellow solid, mp. 
244–246°C [59]. IR (KBr, νmax cm–1): 2954, 1657, 1621, 
1365, 1308, 1265, 957, 704. 1H NMR (CDCl3, 400 MHz, 
TMS): δ 8.24–8.36 (m, 2H), 7.81–7.86 (m, 2H), 7.11–7.34 
(m, 4H, Ar-H), 6.39 (s, 1H, Ar-CH), 3.52–3.61 (m, 2H), 
2.43–2.62 (m, 2H), 2.29 (s, 3H, CH3), 2.00–2.07 (m, 2H); 
13C NMR (CDCl3, 100 MHz): δ 196.0, 193.2, 164.2, 156.4, 
142.4, 136.4, 133.9, 133.4, 129.7, 129.3, 127.7, 127.5, 
120.4, 116.9, 65.5, 37.6, 29.4, 21.6, 21.0. Anal. Calcd. for 
C22H18N2O3 (%): C, 73.73; H, 5.06; N, 7.82; Found (%): C, 
73.65; H, 4.89; N, 7.65.   
(5) 2,3,4,13-Tetrahydro-13-(3-hydroxy-phenyl)-1H-inda- 
zolo[1,2-b]phthalazine-1,6,11-trione (4e). White solid, mp. 
266–268°C [60]; IR (nujol, νmax cm–1): 3404, 2853, 1640, 
1618, 1378, 1311, 1214, 771, 674. 1H NMR (CDCl3, 400 
MHz, TMS): δ 8.24–8.38 (m, 2H), 7.83–7.89 (m, 2H), 
6.73–7.06 (m, 4H, Ar-H), 6.43 (s, 1H, Ar-CH), 4.76 (br s, 
1H, OH), 3.52–3.62 (m, 2H), 2.53–2.68 (m, 2H), 2.22–2.47 
(m, 2H); 13C NMR (CDCl3, 100 MHz): δ 197.3, 165.2, 
163.0, 158.8, 156.2, 139.3, 138.4, 133.7, 132.7, 131.8, 
131.5, 130.3, 129.3, 124.2, 119.3, 68.4, 37.5, 29.8, 25.7. 
Anal. Calcd. for C21H16N2O4 (%): C, 69.99; H, 4.48; N, 7.77; 
Found (%): C, 69.75; H, 4.38; N, 7.62. 
(6) 2,3,4,13-Tetrahydro-13-(4-hydroxy-3-methoxy-phenyl)- 
1H-indazolo[1,2-b]phthalazine-1,6,11-trione (4f).  Yellow 
solid, mp. 202–206°C. IR (nujol, νmax cm–1): 3536, 2920, 
1668, 1596, 1468, 1364, 1272, 1215, 1128, 960, 630. 1H 
NMR (CDCl3, 400 MHz, TMS): δ 8.25–8.36 (m, 2H), 
7.82–7.88 (m, 2H), 6.52–6.56 (m, 3H, Ar-H), 6.38 (s, 1H, 
Ar-CH), 4.73 (br s, 1H, OH), 3.97 (s, 3H, OCH3), 2.51–2.64 
(m, 2H), 2.25–2.42 (m, 2H), 1.96–2.07 (m, 2H); 13C NMR 
(CDCl3, 100 MHz): δ 197.3, 164.3, 152.6, 146.4, 143.2, 
137.6, 130.5, 129.5, 127.3, 120.7, 115.2, 112.1, 110.4, 64.9, 
55.7, 37.8, 27.0, 22.8. Anal. Calcd. for C22H18N2O5 (%): C, 
67.69; H, 4.65; N, 7.18; Found (%): C, 67.56; H, 4.58; N, 
7.02. 
(7) 2,3,4,13-Tetrahydro-13-(4-dimethylamino-phenyl)-1H- 
indazolo[1,2-b]phthalazine-1,6,11-trione (4g). Red solid, 
mp. 255–256°C [59]. IR (nujol, νmax cm–1): 2924, 1672, 
1624, 1365, 1313, 1226, 671. 1H NMR (CDCl3, 400 MHz, 
TMS): δ 8.22–8.32 (m, 2H), 7.79–7.83 (m, 2H), 7.16 (d, J = 
9.0 Hz, 2H), 6.73 (d, J = 8.8 Hz, 2H), 6.40 (s, 1H, Ar-CH), 
3.07 (s, 6H, N(CH3)2), 2.50–2.64 (m, 2H), 2.25–2.37 (m, 
2H), 1.93–2.03 (m, 2H); 13C NMR (CDCl3, 100 MHz): δ 
196.2, 164.5, 154.6, 153.1, 137.2, 133.4, 129.0, 128.4, 128.0, 
126.3, 118.3, 112.6, 65.3, 41.3, 40.7, 30.1, 21.8. Anal.  
Calcd. for C23H21N3O3 (%): C, 71.30; H, 5.46; N, 10.85; 
Found (%): C, 71.16; H, 5.33; N, 10.74. 
(8) 2,3,4,13-Tetrahydro-3,3-dimethyl-13-phenyl-1H-ind- 
azolo[1,2-b]phthalazine-1,6,11-trione (4h).  Light yellow 
solid, mp. 202–204°C [37]. IR (KBr, νmax cm–1): 2959, 1662, 
1623, 1361, 1308, 1262, 791. 1H NMR (CDCl3, 400 MHz, 
TMS): δ 8.25–8.35 (m, 2H), 7.83–7.85 (m, 2H), 7.20–7.41 
(m, 5H, Ar-H), 6.44 (s, 1H, Ar-CH), 3.20 and 3.42 (AB-q 
system, J = 19.04 Hz, 2H), 2.45 (s, 2H), 1.08 (s, 3H, CH3), 
0.97 (s, 3H, CH3); 
13C NMR (CDCl3, 100 MHz): δ 196.4, 
162.2, 155.9, 150.7, 144.0, 128.9, 128.7, 128.3, 127.7, 
127.1, 126.3, 115.6, 64.9, 50.9, 40.8, 28.4, 27.3. Anal. 
Calcd. for C23H20N2O3 (%): C, 74.18; H, 5.41; N, 7.52; 
Found (%): C, 74.03; H, 5.29 ; N, 7.40. 
(9) 2,3,4,13-Tetrahydro-3,3-dimethyl-13-(4-chloro-ph-  
enyl)-1H-indazolo[1,2-b]phthalazine-1,6,11-trione (4i). Light 
yellow solid, mp. 262–266°C [37]. IR (KBr, νmax cm–1): 
2962, 1660, 1624, 1362, 1310, 1263, 791. 1H NMR (CDCl3, 
400 MHz, TMS): δ 8.25–8.36 (m, 2H), 7.85–7.87 (m, 2H), 
7.29–7.36 (m, 4H, Ar-H), 6.41 (s, 1H, Ar-CH), 3.20 and 
3.42 (AB-q system, J = 19.04 Hz, 2H), 2.35 (s, 2H), 1.20 (s, 
3H, CH3), 0.98 (s, 3H, CH3); 
13C NMR (CDCl3, 100 MHz): δ 
196.4, 162.4, 155.7, 151.0, 142.6, 134.6, 132.0, 129.7, 128.5, 
128.2, 127.7, 115.2, 64.3, 50.8, 40.8, 29.3, 27.3. Anal. 
Calcd. for C23H19ClN2O3 (%): C, 67.90; H, 4.71; N, 6.89; 
Found (%): C, 67.76; H, 4.62; N, 6.75. 
(10) 2,3,4,13-Tetrahydro-3,3-dimethyl-13-(4-methoxy-  
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phenyl)-1H-indazolo[1,2-b]phthalazine-1,6,11-trione (4j).  
White solid, mp. 202–206°C [58]. IR (KBr, νmax cm–1): 
3015, 2898, 1664, 1495, 1377, 1304, 1262, 791. 1H NMR 
(CDCl3, 400 MHz, TMS): δ 8.25–8.33 (m, 2H), 7.80–7.86 
(m, 2H), 6.71–7.18 (m, 4H, Ar-H), 6.39 (s, 1H, Ar-CH), 
3.71 (s, 3H, OCH3), 3.19 and 3.42 (AB-q system, J = 19.1 
Hz, 2H), 2.42 (s, 2H), 1.07 (s, 3H, CH3), 0.97 (s, 3H, CH3); 
13C NMR (CDCl3, 100 MHz): δ 195.5, 162.0, 159.4, 157.7, 
143.1, 136.2, 132.5, 129.3, 128.7, 127.6. 115.8, 113.4, 55.1, 
50.7, 40.8, 32.2, 29.3, 27.3. Anal. Calcd. for C24H22N2O4 
(%): C, 71.63; H, 5.51; N, 6.96; Found (%): C, 71.51; H, 
5.38; N, 6.85. 
(11) 2,3,4,13-Tetrahydro-3,3-dimethyl-13-(4-nitro-phenyl)- 
1H-indazolo[1,2-b]phthalazine-1,6,11-trione (4k). Creamy 
white solid, mp. 224–226°C [58]. IR (KBr, νmax cm–1): 3013, 
2959, 1661, 1593, 1375, 1345, 1262, 851. 1H NMR (CDCl3, 
400 MHz, TMS): δ 8.22–8.38 (m, 2H), 7.86–7.89 (m, 2H), 
7.23–7.62 (m, 4H, Ar-H), 6.51 (s, 1H, Ar-CH), 3.23 and 
3.43 (AB-q system, J = 21.2 Hz, 2H), 2.47 (s, 2H), 1.23 (s, 
3H, CH3), 1.11 (s, 3H, CH3); 
13C NMR (CDCl3, 100 MHz): 
δ 196.1, 162.9, 151.2, 148.7, 146.5, 146.1, 133.7, 132.3, 
129.2, 127.6, 123.5, 114.9, 63.8, 50.4, 46.9, 46.3, 29.5, 27.4; 
Anal. Calcd. for C23H19N3O5 (%): C, 66.18; H, 4.59; N, 
10.07; Found (%): C, 66.08; H, 4.44; N, 10.02. 
(12) 2,3,4,13-Tetrahydro-3,3-dimethyl-13-(4-methyl-ph- 
enyl)-1H-indazolo[1,2-b]phthalazine-1,6,11-trione (4l). Yel-
low solid, mp. 226–228°C [37]. IR (KBr, νmax cm–1): 3017, 
2960, 2898, 1664, 1492, 1350, 1263, 791. 1H NMR (CDCl3, 
400 MHz, TMS): δ 8.23–8.33 (m, 2H), 7.80–7.86 (m, 2H), 
6.98–7.16 (m, 4H, Ar-H), 6.39 (s, 1H, Ar-CH), 3.19 and 
3.41 (AB-q system, J = 20.5 Hz, 2H), 2.40 (s, 2H), 2.22 (s, 
3H, CH3), 1.07 (s, 3H, CH3), 0.96 (s, 3H, CH3);
 13C NMR 
(CDCl3, 100 MHz): δ 196.5, 162.1, 158.3, 142.7, 141.1, 
136.3, 135.7, 132.3, 128.8, 128.2, 126.7, 115.5, 64.5, 50.7, 
40.8, 29.2, 27.3, 20.5. Anal. Calcd. for C24H22N2O3 (%): C, 
74.59; H, 5.74; N, 7.25; Found (%): C, 74.50; H, 5.65; N, 
7.12. 
(13) 2,3,4,13-Tetrahydro-3,3-dimethyl-13-(2-hydroxy-phe- 
nyl)-1H-indazolo[1,2-b]phthalazine-1,6,11-trione (4m). Yell- 
ow solid, mp. 184–188°C.  IR (KBr, νmax cm–1) 2896, 1662, 
1492, 1377, 1329, 1262, 1081, 791. 1H NMR (CDCl3, 400 
MHz, TMS): δ 10.99 (br s, 1H, OH), 8.25–8.33 (m, 2H), 
7.84–7.86 (m, 2H), 6.96–7.55 (m, 4H, Ar-H), 6.34 (s, 1H, 
Ar-CH), 2.43 and 2.60  (AB-q system, J = 17.3 Hz, 2H), 
2.32 (s, 2H), 1.02 (s, 3H, CH3), 0.96 (s, 3H, CH3); 
13C NMR 
(CDCl3, 100 MHz): δ 201.0, 196.1, 169.4, 161.5, 150.7, 
137.0, 133.4, 131.8, 128.7, 128.0, 127.5, 124.6, 120.6, 
115.7, 111.0, 52.2, 43.2, 41.5, 27.2, 26.4. Anal. Calcd. for 
C23H20N2O4 (%): C, 71.12; H, 5.12; N, 7.21; Found (%): C, 
70.98; H, 5.03; N, 7.08. 
(14) 2,3,4,13-Tetrahydro-3,3-dimethyl-13-benzo-[1,3]-dioxol 
-5-yl-1H-indazolo[1,2-b]phthalazine-1,6,11-trione (4n). Ye- 
llow solid, mp. 194–198°C;  IR (KBr, νmax cm–1): 2958, 
1662, 1624, 1489, 1361, 1261, 825. 1H NMR (CDCl3, 400 
MHz, TMS): δ 8.26–8.36 (m, 2H), 7.84–7.86 (m, 2H), 
6.64–6.77 (m, 3H, Ar-H), 6.34 (s, 1H, Ar-CH), 5.92 (s, 
CH2-piperonyl), 3.20 and 3.42 (AB-q system, J = 19.8 Hz, 
2H), 2.43 (s, 2H), 1.10 (s, 3H, CH3), 1.01 (s, 3H, CH3); 
13C 
NMR (CDCl3, 100 MHz): δ 195.5, 162.1, 155.7, 147.7, 
145.9, 138.3, 134.6, 133.2, 129.8, 127.8, 121.5, 118.8, 
115.6, 109.07, 100.7, 64.7, 50.7, 40.8, 29.2, 27.4. Anal. 
Calcd. for C24H20N2O5 (%): C, 69.22; H, 4.84; N, 6.73; 
Found (%): C, 69.16; H, 4.73; N, 6.70. 
(15) 2,3,4,13-Tetrahydro-3,3-dimethyl-13-(2-hydroxy-na- 
phthalen-1-yl)-1H-indazolo[1,2-b]phthalazine-1,6,11-trione 
(4o).  Brown solid, mp. 156–160°C; IR (KBr, νmax cm–1): 
3155, 2958, 2927, 2855, 2253, 1718, 1628, 1466, 1376, 
1293, 908, 734. 1H NMR (CDCl3, 400 MHz, TMS): δ 10.72 
(br s, 1H, OH), 8.23–8.30 (m, 2H), 7.90–7.93 (m, 2H), 
7.54–7.74 (m, 6H, Ar-H), 6.32 (s, 1H, Ar-CH), 3.48 and 
3.61 (AB-q system, J = 17.6 Hz, 2H), 2.34 (s, 2H), 1.12 (s, 
3H, CH3), 1.01 (s, 3H, CH3); 
13C NMR (CDCl3, 100 MHz): 
δ 193.2, 164.8, 160.2, 153.4, 139.1, 132.8, 132.4, 131.3, 
129.4, 129.1, 128.5, 127.7, 125.2, 124.4, 122.9, 119.1, 
118.5, 111.2, 49.6, 46.1, 43.1, 25.2, 22.7. Anal. Calcd. for 
C27H22N2O4 (%): C, 73.96; H, 5.06; N, 6.39; Found (%): C, 
73.85; H, 4.93; N, 6.32. 
(16) 2,3,4,13-Tetrahydro-13-ethyl-1H-indazolo[1,2-b]-  
phthalazine-1,6,11-trione (4p).  Yellow solid, mp. 164– 
166°C. IR (KBr, νmax cm–1): 3461, 2877, 1731, 1652, 1456, 
1372, 1291, 1176, 956, 892, 795, 701. 1H NMR (CDCl3, 
400 MHz, TMS): δ 8.28–8.32 (m, 2H), 7.81–7.85 (m, 2H), 
5.67 (m, 1H, CHN), 2.45–2.54 (m, 2H, CH2), 2.27–2.33 (m, 
2H, CH2), 2.17–2.23 (m, 2H, CH2), 1.96–2.06 (m, 2H, 
CH2CH3), 0.70 (t, 3H, CH3); 
13C NMR (CDCl3, 100 MHz): 
δ 197.3, 165.5, 162.2, 141.5, 134.4, 133.4, 128.9, 128.7, 
127.8, 127.4, 117.6, 61.5, 37.0, 29.6, 22.3, 20.4, 9.9. Anal. 
Calcd. for C17H16N2O3 (%): C, 68.91; H, 5.44; N, 9.45; 
Found (%): C, 68.74; H, 5.27; N, 9.34. 
(17) 2,3,4,13-Tetrahydro-13-propyl-1H-indazolo[1,2-b]-  
phthalazine-1,6,11-trione (4q).  White solid, mp. 172– 
174°C [58]. IR (KBr, νmax cm–1): 3165, 2963, 1662, 1492, 
1377, 1262, 1081, 825, 791, 683. 1H NMR (CDCl3, 400 
MHz, TMS): δ 8.07–8.22 (m, 2H), 7.67–7.70 (m, 2H), 4.91 
(m, 1H, CHN), 2.41–2.46 (m, 2H, CH2), 2.10–2.17 (m, 2H, 
CH2), 1.47–1.54 (q, 2H, CH2CH2), 1.31–1.43 (m, 2H, 
CH2CH3), 1.17–1.26 (m, 2H, CH2), 0.76–0.83 (t, 3H, CH3); 
13C NMR (CDCl3, 100 MHz): δ 195.4, 161.2, 158.9, 143.3, 
132.5, 132.3, 128.4, 121.3, 52.2, 41.3, 32.2, 29.7, 18.4, 18.2, 
13.9. Anal. Calcd. for C18H18N2O3 (%): C, 69.66; H, 5.85; N, 
9.03; Found (%): C, 69.53; H, 5.76; N, 8.94. 
(18) 2,3,4,13-Tetrahydro-3,3-dimethyl-13-isobutyl-1H-  
indazolo[1,2-b]phthalazine-1,6,11-trione (4r).  Yellow solid, 
mp. 135–137°C [57]. IR (KBr, νmax cm–1): 3166, 2896, 1663, 
1492, 1377, 1262, 1082, 825, 791, 683. 1H NMR (CDCl3, 
400 MHz, TMS): δ 7.90–7.95 (m, 2H), 7.51–7.56 (m, 2H), 
4.98 (m, 1H, CHN), 3.26 and 3.43 (AB-q system J = 20.52 
Hz, 2H), 2.33 (s, 2H, CH2), 2.10–2.15 (m, 2H, CH-CH2), 
1.87–1.92 (m, 1H, CH(CH3)2), 1.10 (s, 3H, CH3), 0.98 (s, 
3H, CH3), 0.83–0.85 (d, 3H, CH3), 0.66–0.69 (d, 3H, CH3); 
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13C NMR (CDCl3, 100 MHz): δ 194.7, 160.3, 158.8, 137.7, 
130.4, 129.2, 126.8, 119.3, 51.2, 38.3, 36.4, 31.4, 26.3, 24.2, 
22.3, 20.1. Anal. Calcd. for C21H24N2O3 (%): C, 71.57; H, 
6.86; N, 7.95; Found (%): C, 71.44; H, 6.74; N, 7.80. 
(19) 2,3,4,13-Tetrahydro-3,3-dimethyl-13-hexyl-1H-  
indazolo[1,2-b]phthalazine-1,6,11-trione (4s).  Yellow solid, 
mp. 84–86°C [57]. IR (KBr, νmax cm–1): 2958, 2926, 1660, 
1632, 1462, 1375, 1288, 1180, 960, 892, 793, 699. 1H NMR 
(CDCl3, 400 MHz, TMS): δ 8.24–8.34 (m, 2H), 7.86–7.94 
(m, 2H), 5.67 (m, 1H, CHN), 3.18 and 3.34 (AB-q system J 
= 19.6 Hz, 2H), 2.47–2.51 (m, 1H, CHN), 2.40–2.44 (dd, 
2H, CH2C), 2.12–2.14 (m, 1H, CH), 1.15–1.33 (m, 12H, 2 
CH3 and 3 CH2), 1.10–1.14 (m, 2H, CH2), 0.85–0.87 (t, 3H, 
CH3); 
13C NMR (CDCl3, 100 MHz): δ 192.7, 160.2, 158.6, 
142.2, 132.5, 131.8, 128.2, 121.7, 55.8, 52.4, 33.1, 31.4, 
28.6, 27.0, 25.1, 23.5, 17.4, 14.5. Anal. Calcd. for 
C23H28N2O3 (%): C, 72.60; H, 7.42; N, 7.36; Found (%): C, 
72.53; H, 7.31; N, 7.25. 
2  Results and discussion 
Initially, equimolar amounts of phthalhydrazide 1, benzal-
dehyde 2a and cyclohexane-1,3-dione 3a were stirred at 
ambient temperature in ethanol. After 22 h, yields of only 
36% were obtained. To both improve the yield and optimize 
the reaction conditions, various Lewis acids were screened 
in a model reaction and the best yield was obtained using 
CAN as a catalyst (Scheme 1). The results are tabulated in 
Table 2. 
A study was then done to determine the optimal loading 
of CAN. The reaction was carried out with varying amounts 
of catalyst, in the synthesis of 4a. With 2 mol% CAN, under 
similar conditions, a significant improvement was observed 
 
 
Scheme 1  Model reaction for the synthesis of 1H-indazolo[1,2-b]- 
phthalazine-1,6,11-triones. 
Table 2  Screening of various Lewis acids for the model reactiona) 
Entry Catalyst Time (h) Yield (%)b) 
1 InCl3 12 62 
2 FeCl3 8 46 
3 I2 5.5 66 
4 CuSO4 7 71 
5 CAN 2 94 
6 ZnCl2 10 53 
7 AlCl3 8.5 57 
a) Reaction conditions: phthalhydrazide 1 (1 mmol), benzaldehyde 2a 
(1 mmol), cyclohexane-1,3-dione 3a (1 mmol); catalyst: 5 mol%; solvent: 
PEG 400 (2 mL); T: 50°C. b) Isolated yields. 
and the yield of 4a was dramatically enhanced to 68% after 
stirring the mixture for 8 h (Table 3, Entry 2). Upon in-
creasing the loading to 5 mol%, a decreased reaction time of 
only 2 h was required, and the product yield increased re-
markably from 68% to 94% (Table 3, Entry 3). Although 
required reaction time remained the same upon using    
10 mol% CAN, the yield actually decreased from 94% to 
76% (Table 3, Entry 4). A possible explanation for this 
lower product yield, is that the substrate (aldehyde) or 
product may be destroyed in the presence of excess amounts 
of CAN (10 mol%). This shows that the catalyst concentra-
tion plays a major role in the optimization of the product 
yield. 
The effect of temperature was also evaluated for the 
model reaction. The reaction proceeded poorly at room 
temperature. Elevating the reaction temperature proved 
helpful and the yield of the desired product 4a increased 
considerably. We were pleased to find that the reaction 
proceeded smoothly, and to almost complete conversion at 
50°C, affording 4a in 94% yield within 2 h. Increasing the 
temperature beyond 50°C, reduces the product yield due to 
the oxidation of the reactant (aldehyde) by CAN at high 
temperature. To assess the reaction efficiencies in different 
solvents, a variety of solvent systems were screened using 
the model reaction. The results are summarized in Figure 1. 
PEG 400 is the optimal solvent for this reaction giving ex-
cellent yields. 
The optimum conditions for the model case were then 
applied to various aromatic and aliphatic aldehydes as 
Table 3  Catalytic activity evaluation for the synthesis of 1H-indazolo 
[1,2-b]phthalazine-1,6,11-trionesa) 
Entry CAN (mol%) Time (h) Yield (%)b) 
1 0 18 35 
2 2 8 68 
3 5 2 94 
4 10 2 76 
a) Reaction conditions: phthalhydrazide 1 (1 mmol), benzaldehyde 2a 
(1 mmol), cyclohexane-1,3-dione 3a (1 mmol); solvent: PEG 400 (2 mL); 
T: 50°C. b) Isolated yields. 
 
 
Figure 1  Effect of various solvents on the synthesis of 1H-indazolo 
[1,2-b]phthalazine-1,6,11-triones. Reaction conditions: phthalhydrazide 1 
(1 mmol), benzaldehyde 2a (1 mmol), cyclohexane-1,3-dione 3a (1 mmol); 
catalyst: CAN (5 mol%); solvent: x (2 mL); T: 50°C. Isolated yields. 
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shown in Table 3. Aromatic aldehydes with both elec-
tron-donating and electron-withdrawing substituents pro-
ceeded smoothly to give excellent product yields. They also 
required reduced reaction times compared to aliphatic alde-
hydes, which reacted slowly to give only moderate yields 
(Scheme 2, Table 1, Entries 1–15).  It is noteworthy that 
until now there has only been one report on the synthesis of 
1H-indazolo[1,2-b]phthalazine-1,6,11-triones using aliphat-
ic aldehydes [57].  
To establish the recyclability of the PEG 400, the reac-
tion mixture was kept in a dry ice-acetone bath to precipi-
tate the PEG 400. The desired product was extracted with 
solvent ether, in which the PEG 400 is immiscible. The re-
maining PEG 400 phase was reused in subsequent reactions. 
The reaction proceeded cleanly, exhibiting consistent results 
for up to four runs. A weight loss of approximately 5% was 
observed from cycle to cycle because of mechanical losses. 
 
 
Scheme 2  CAN promoted synthesis of 1H-indazolo[1,2-b]phthalazine- 
1,6,11-triones. 
3  Conclusion 
A novel and efficient catalytic method has been developed 
for the preparation of 1H-indazolo[1,2-b]phthalazine-1,6,11- 
trione derivatives, using a ceric ammonium nitrate catalyst. 
The notable features of this clean one-pot procedure are the 
mild reaction conditions, improved yields, enhanced reac-
tion rates, solvent recyclability and operational simplicity. 
This protocol represents a useful and attractive process for 
the synthesis of 1H-indazolo[1,2-b]phthalazine-1,6,11-trione 
derivatives.  
Authors (Ritika Chauhan and Anwar Jahan) are thankful to University 
Grants Commission for the grant of Junior Research Fellowship. We also 
express our thanks to the Director of University Science and Instrumenta-
tion Centre, University of Delhi, Delhi for providing the spectral analysis 
data. 
1 Zhu J, Bienayme H. Multicomponent Reactions. Wiley-VCH: Wein-
heim, 2005 
2 Dömling A. Recent developments in isocyanide based multicompo-
nent reactions in applied chemistry. Chem Rev, 2006, 106: 17–89 
3 Ramón D J, Yus M. Asymmetric multicomponent reactions 
(AMCRs): The new frontier. Angew Chem Int Ed, 2005, 44: 1602– 
1634 
4 Simon C, Constantieux T, Rodriguez J. Utilisation of 1,3-dicarbonyl 
derivatives in multicomponent reactions. Eur J Org Chem, 2004, 
4957–4980 
5 Orru R V A, de Greef M. Recent advances in solution-phase multi-
component methodology for the synthesis of heterocyclic compounds. 
Synthesis, 2003, 1471–1499 
6 Bienayme H, Hulme C, Oddon G, et al. Maximizing synthetic effi-
ciency: Multi-component transformations lead the way. Chem Eur J, 
2000, 6: 3321–3329 
7 Ulaczyk-Lesanko A, Hall D G. Wanted: New multicomponent reac-
tions for generating libraries of polycyclic natural products. Curr 
Opin Chem Biol, 2005, 9: 266–276 
8 Weber L. The application of multi-component reactions in drug dis-
covery. Curr Med Chem, 2002, 9: 2085–2093 
9 Hulme C, Gore V. Multi-component reactions: Emerging chemistry 
in drug discovery “from xylocain to crixivan”. Curr Med Chem, 2003, 
10: 51–80 
10 Dömling A, Ugi I. Multicomponent reactions with isocyanides. An-
gew Chem Int Ed, 2000, 39: 3168–3210 
11 Kappe C O. Recent advances in the Biginelli dihydropyrimidine syn-
thesis. New tricks from an old dog. Acc Chem Res, 2000, 33: 
879–888 
12 Franklin E C, Bergstrom F W. Heterocyclic nitrogen compounds 
PART I. Pentacyclic compounds. Chem Rev, 1935, 16: 305–361 
13 Bergstrom F W. Heterocyclic nitrogen compounds. Part II A. Hexa-
cyclic compounds: Pyridine, quinoline, and isoquinoline. Chem Rev, 
1944, 35: 77–277 
14 Lichtenthaler F W. Unsaturated O- and N-heterocycles from carbo-
hydrate feedstocks. Acc Chem Res, 2002, 35: 728–737 
15 Litvinov V P. Multicomponent cascade heterocyclization as a prom-
ising route to targeted synthesis of polyfunctional pyridines. Russ 
Chem Rev, 2003, 72: 69–85 
16 Xu Y, Guo Q X. Syntheses of heterocyclic compounds under micro-
wave irradiation. Heterocycles, 2004, 63: 903–974 
17 Vaughan W R. The chemistry of the phthalazines. Chem Rev, 1948, 
43: 447–508 
18 Clement R A. The oxidation of 2,3-dihydrophthalazine-1,4-dione 
with lead tetraacetate. Phthalazine-1,4-dione and 1,4-dihydropyri- 
dazino[1,2-b]-phthalazine-6,ll-dione. J Org Chem, 1960, 25: 1724– 
1727 
19 Indelicato J M, Pasini C E. The acylating potential of -Lactam anti-
bacterials: Base hydrolysis of bicyclic pyrazolidinones. J Med Chem, 
1988, 31: 1227–1230 
20 Kappe T, Kos C. A facile synthesis of 1-oxo-1H-pyrazolo[1,2-a] py-
razol-4-ium-3-olates. Synthesis, 1989, 629–630 
21 Turk C, Svete J, Stanovnik B, et al. Regioselective 1,3-dipolar cy-
cloadditions of (1Z)-1-(Arylmethylidene)-5,5-dimethyl-3-oxopyra- 
zolidin-1-ium-2-ide azomethine imines to acetylenic dipolarophiles. 
Helv Chim Acta, 2001, 84: 146–156 
22 Clark M P, Laughlin S K, Laufersweiler M J, et al. Development of 
orally bioavailable bicyclic pyrazolones as inhibitors of tumor necro-
sis factor-α production. J Med Chem, 2004, 47: 2724–2727 
23 Grasso S, De Sarro G, De Sarro A, et al. Synthesis and anticonvulsant 
activity of novel and potent 6,7-methylenedioxyphthalazin-1(2H)- 
ones. J Med Chem, 2000, 43: 2851–2859 
24 Nomoto Y, Obase H, Takai H, et al. Studies on cardiotonic agents. II. 
Synthesis of novel phthalazine and 1,2,3-benzotriazine derivatives. 
Chem Pharm Bull, 1990, 38: 2179–2183 
25 Watanabe N, Kabasawa Y, Takase Y, et al. 4-Benzylamino- 
1-chloro-6-substituted phthalazines: Synthesis and inhibitory activity 
toward phosphodiesterase 5. J Med Chem, 1998, 41: 3367–3372 
26 Ryu C K, Park R E, Ma M Y, et al. Synthesis and antifungal activity 
of 6-arylamino-phthalazine-5,8-diones and 6,7-bis(arylthio)-phthal- 
azine-5,8-diones. Bioorg Med Chem Lett, 2007, 17: 2577–2580 
27 Li J, ZhaoY F, Yuan X Y, et al. Synthesis and anticancer activities of 
novel 1,4-disubstituted phthalazines. Molecules, 2006, 11: 574–582 
28 Sinkkonen J, Ovcharenko V, Zelenin K N, et al. 1H and 13C NMR 
study of 1-hydrazino-2,3-dihydro-1H-pyrazolo[1,2-a]pyridazine-5,8- 
diones and -1H-pyrazolo[1,2-b]phthalazine-5,10-diones and their 
ring-chain tautomerism. Eur J Org Chem, 2002, 2046–2053 
29 Mavel S, Thery I, Gueiffier A. Synthesis of imidazo[2,1-a]    
phthalazines, potential inhibitors of p38 MAP kinase. Prediction of 
binding affinities of protein ligands. Arch De Pharm, 2002, 335: 7–14 
30 Carling R W, Moore K W, Street L J, et al. 3-Phenyl-6-(2-pyridyl) 
methyloxy-1,2,4-triazolo[3,4-a]phthalazines and Analogues: High-  
 Mazaahir K, et al.   Chin Sci Bull   June (2012) Vol.57 No.18 2279 
affinity γ-aminobutyric acid—A benzodiazepine receptor ligands 
with α2, α3, and α5-subtype binding selectivity over α1. J Med Chem, 
2004, 47: 1807–1822 
31 Street L J, Sternfeld F, Jelley R A, et al. Synthesis and biological 
evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro (7,10-ethano)-1,2,4- 
triazolo[3,4-a]phthalazines and analogues as subtype-selective in-
verse agonists for the GABAAα5. benzodiazepine binding site. J Med 
Chem, 2004, 47: 3642–3657 
32 Imamura Y, Noda A, Imamura T, et al. A novel methylthio metabo-
lite of s-triazolo[3,4-a]phthalazine, a lead compound for the devel-
opment of antianxiety drugs, in rats. Life Sci, 2003, 74: 29–36 
33 Kim J S, Lee H J, Suh M E, et al. Synthesis and cytotoxicity of 
1-substituted 2-methyl-1H-imidazo[4,5-g]phthalazine-4,9-dione de-
rivatives. Bioorg Med Chem, 2004, 12: 3683–3686 
34 Lebsack A D, Gunzner J, Wang B, et al. Identification and synthesis 
of [1,2,4]triazolo[3,4-a]phthalazine derivatives as high-affinity lig-
ands to the a2-1 subunit of voltage gated calcium channel. Bioorg 
Med Chem Lett, 2004, 14: 2463–2467 
35 Wu H, Chen X M, Wan Y, et al. Synthesis and luminescence of 
7-amino-2H-indazolo[2,1-b]phthalazine-1,6,11(13H)-triones catalyzed 
by silica sulfuric acid. Lett Org Chem, 2009, 6: 219–223 
36 Hwang J Y, Choi H S, Gong Y D. Solid-phase synthesis of 
[1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine de-
rivatives. Tetrahedron Lett, 2005, 46: 3107–3110 
37 Shaterian H R, Ghashang M, Feyzi M, et al. Silica sulfuric acid as an 
efficient catalyst for the preparation of 2H-indazolo[2,1-b]phthala- 
zine-triones. Appl Catal A, 2008, 345: 128–133 
38 Wang H J, Zhang X N, Zhang Z H, et al. Highly efficient three- 
component synthesis of 1H-indazolo[1,2-b]phthalazinetrione deriva-
tives catalyzed by heteropolyacids. Monatsh Chem, 2010, 141: 
425–430 
39 Fazaeli R, Aliyan H, Fazaeli N, et al. Heteropoly acid in ionic liq-
uid—An efficient catalyst for the preparation of 2H-indazolo 
[2,1-b]phthalazine-triones. Open Catal J, 2010, 3: 14–18 
40 Mosaddegh E, Hassankhani A. A rapid, one-pot, four-component 
route to 2H-indazolo[2,1-b]-phthalazine-triones. Tetrahedron Lett, 
2011, 52: 488–490 
41 Sayyafi M, Seyyedhamzeh M, Khavasi H R, et al. One-pot, three- 
component route to 2H-indazolo[2,1-b]phthalazine-triones. Tetrahe-
dron, 2008, 64: 2375–2378 
42 Nair V, Deepthi A. Cerium (IV) ammonium nitrates: A versatile sin-
gle-electron oxidant. Chem Rev, 2007, 107: 1862–1891 
43 Nair V, Balagopal L, Rajan R, et al. Recent advances in synthetic 
transformations mediated by cerium(IV) ammonium nitrate. Acc 
Chem Res, 2004, 37: 21–30 
44 More S V, Sastry M N V, Yao C F, et al. Cerium (IV) ammonium ni-
trate (CAN) as a catalyst in tap water: A simple, proficient and green 
approach for the synthesis of quinoxalines. Green Chem, 2006, 8: 
91–95 
45 Surendra K, Krishnaveni N S, Rao K R, et al. A mild and efficient 
procedure for the oxidation of epoxides and aziridines using      
cerium(IV) ammonium nitrate and NBS. Tetrahedron Lett, 2005, 46: 
4111–4113 
46 Chen J, Spear S K, Huddleston J G, et al. Polyethylene glycol and 
solutions of polyethylene glycol as  green reaction media. Green 
Chem, 2005, 7: 64–82 
47 Zhang Z H, Yin L, Wang Y M, et al. Indium tribromide in 
poly(ethylene glycol) (PEG): A novel and efficient recycle system for 
chemoselective deprotection of 1,1-diacetates. Green Chem, 2004, 6: 
563–565 
48 Kumar R, Chaudhary P, Nimesh S, et al. Polyethylene glycol as a 
non-ionic liquid solvent for michael addition reaction of amines to 
conjugated alkenes. Green Chem, 2006, 8: 356–358 
49 Harris J M. Poly (Ethylene Glycol) Chemistry. In Biotechnological 
Applications. New York: Plenum Press, 1992. 3 
50 Harris J M, Zalipsky S. Poly(Ethylene Glycol): Chemistry and Bio-
logical Applications (ACS Symposium). Washington DC: American 
Chemical Society, 1998 
51 Mao J, Guo J, Fang F, et al. Highly efficient copper(0)-catalyzed Su-
zukie Miyaura cross-coupling reactions in reusable PEG-400. Tetra-
hedron, 2008, 64: 3905–3911 
52 Mukhopadhyay C, Tapaswi P K. PEG-mediated catalyst-free expedi-
tious synthesis of 2-substituted benzimidazoles and bis-benzimi- 
dazoles under solvent-less conditions. Tetrahedron Lett, 2008, 49: 
6237–6240 
53 Kouznetsov V V, Merchan Arenas D R, Romero Bohorquez A R. 
PEG-400 as green reaction medium for Lewis acid-promoted cy-
cloaddition reactions with isoeugenol and anethole. Tetrahedron Lett, 
2008, 49: 3097–3100 
54 Kidwai M, Bhatnagar D. Ceric ammonium nitrate (CAN) catalyzed 
synthesis of N-substituted decahydroacridine-1,8-diones in PEG. 
Tetrahedron Lett, 2010, 51: 2700–2703 
55 Kidwai M, Bhatnagar D, Chauhan R. Potassium carbonate-mediated 
green and efficient synthesis of imidazo[2,1-b]-1,3,4-thiadiazoles us-
ing PEG as solvent. J Heterocycl Chem, 2011, doi: 10.1002/jhet.1037  
56 Kidwai M, Chauhan R, Bhatnagar D. Eco-friendly synthesis of 
2-aminothiazoles using Nafion-H as a recyclable catalyst in 
PEG-water solvent system. J Sulf Chem, 2011, 32: 37–44 
57 Ghorbani-Vaghei R, Karimi-Nami R, Toghraei-Semiromi Z, et al. 
One-pot synthesis of aliphatic and aromatic 2H-indazolo[2,1-b] 
phthalazine-triones catalyzed by N-halosulfonamides under sol-
vent-free conditions. Tetrahedron, 2011, 67: 1930–1937  
58 Sabitha G, Srinivas C, Raghavendar A, et al. Phosphomolybdic acid 
(PMA)-SiO2 as a heterogeneous solid acid catalyst for the one-pot 
synthesis of 2H-indazolo[1,2-b]phthalazine-triones. Helv Chim Acta, 
2010, 93: 1375–1380 
59 Khurana J M, Magoo D. Efficient one-pot synthesis of 2H-      
indazolo[2,1-b]phthalazine-triones by catalytic H2SO4 in water-  
ethanol or ionic liquid. Tetrahedron Lett, 2009, 50: 7300–7303 
60 Nagarapu L, Bantu R, Mereyala H B, et al. TMSCl-mediated one-pot, 
three-component synthesis of 2H-indazolo[2,1-b]phthalazine-triones. 
J Heterocycl Chem, 2009, 46: 728–731 
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
 
